|Daily Range||$67.64 - $69.30|
|52-Week Range||$47.72 - $80.67|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,749,743|
|Current FY EPS||-$1.19|
BioMarin Pharmaceutical (BMRN) Description
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/
As investors look back at 2013, some of the most compelling lessons for succeeding in treating rare disease have been taught by BioMarin.
BioMarin, Orexigen and Merrimack were among the biotech stocks that made headlines last week.